These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 6105797

  • 1. Antipsychotic drugs: differential effects on dopamine neurons in basal ganglia and mesocortex following chronic administration in human and nonhuman primates.
    Roth RH, Bacopoulos NG, Bustos G, Redmond DE.
    Adv Biochem Psychopharmacol; 1980; 24():513-20. PubMed ID: 6105797
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Brain homovanillic acid: regional changes following chronic antipsychotic drug administration.
    Bowers MB, Rozitis A.
    Adv Biochem Psychopharmacol; 1977; 16():639-44. PubMed ID: 18907
    [No Abstract] [Full Text] [Related]

  • 4. Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs.
    Lidow MS, Goldman-Rakic PS.
    J Pharmacol Exp Ther; 1997 Nov; 283(2):939-46. PubMed ID: 9353417
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals.
    See RE, Chapman MA.
    Crit Rev Neurobiol; 1994 Nov; 8(1-2):85-124. PubMed ID: 7907282
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of dopamine agonists on neurones in the caudate nucleus and cerebral cortex of cats chronically treated with neuroleptics.
    Bioulac B, Boulard G, Vincent JD, Puil E.
    Neuropharmacology; 1978 Nov; 17(11):965-9. PubMed ID: 31577
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Typical and atypical antipsychotic drugs target dopamine and cyclic AMP-regulated phosphoprotein, 32 kDa and neurotensin-containing neurons, but not GABAergic interneurons in the shell of nucleus accumbens of ventral striatum.
    Ma J, Ye N, Cohen BM.
    Neuroscience; 2006 Sep 01; 141(3):1469-80. PubMed ID: 16781818
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Differential effect of typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medical prefrontal cortical cells: a microiontophoretic study.
    Ashby CR, Edwards E, Harkins KL, Wang RY.
    Eur J Pharmacol; 1989 Aug 03; 166(3):583-4. PubMed ID: 2572432
    [No Abstract] [Full Text] [Related]

  • 20. Adaptive changes of the striatal dopamine system induced by repeated administration of neuroleptics and ergot derivatives.
    Bürki HR.
    Adv Biochem Psychopharmacol; 1980 Aug 03; 24():65-8. PubMed ID: 6105806
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.